Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Thermo Fisher Scientific's Olink Platform Selected for World's Largest Human Proteomics Study

January 14, 2025
Thermo Fisher Scientific's Olink platform has been chosen for the world's largest human proteomics study, marking a significant milestone for the company. The study aims to map the entire human proteome and uncover new insights into human biology and disease. Thermo Fisher's Olink platform, known for its advanced protein analysis capabilities, will play a crucial role in this groundbreaking research. With its high sensitivity and accuracy, the Olink platform will enable researchers to analyze thousands of proteins simultaneously, providing a comprehensive understanding of the complex network of proteins in the human body. Investors are optimistic about the potential impact of this study, with TMO stock showing positive momentum in recent weeks. For a more detailed analysis and forecast of TMO stock, it is recommended to consult professionals at Stocks Prognosis.

Find out how the THERMO FISHER SCIENTIFIC INC. rate is expected to change

Get Forecast for TMO

Investor opinions & comments:

While this study sounds promising, I wonder if it will actually deliver on its goal to map the entire human proteome. It seems like a huge undertaking
— from TylerGonzalez at 01-17-2025 16:53
Investors are right to be optimistic about the potential impact of this study. It could lead to new discoveries and advancements in the field of proteomics
— from MadisonReyes at 01-17-2025 07:12
I'm not convinced that mapping the entire human proteome will provide meaningful insights into human biology and disease. I think there are other areas of research that could be more fruitful
— from RiskyRachel at 01-17-2025 04:32
This study could have significant implications for the medical field. I'm curious to know how it will contribute to our knowledge of human health and potential treatments
— from AnnaDuncan at 01-17-2025 03:28
This is a groundbreaking study that could lead to major advancements in our understanding of human biology and disease. I'm excited to see what new insights will be uncovered
— from CapitalChris at 01-16-2025 08:37
The Olink platform's advanced protein analysis capabilities make it the perfect tool for this study. I can't wait to see the results
— from AndrewRobinson at 01-15-2025 18:00
I'm skeptical about the accuracy and reliability of the Olink platform. Can it really analyze thousands of proteins simultaneously without compromising the results?
— from WealthyWillie at 01-15-2025 14:47
Thermo Fisher Scientific's stock showing positive momentum is a reflection of the confidence investors have in the company and the potential success of this study
— from WealthyWes at 01-15-2025 02:05
This is a significant milestone for Thermo Fisher Scientific. The fact that their Olink platform was selected for such an important study is a testament to its capabilities
— from SamanthaEvans at 01-14-2025 08:13
If you want to leave a comment, then you need Login or Register





Other news for TMO

TMOJune 17, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with 10.84% Profit: QuantWave Analytics  ~1 min.

Thermo Fisher Scientific Inc. (NYSE: TMO) recently achieved a price target forecast as predicted by QuantWave, resulting in a profit of 10.84%....

TMOMay 21, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with 9.69% Profit on QuantWave Platform  ~2 min.

Thermo Fisher Scientific Inc. (TMO) recently achieved a significant milestone on QuantWave, an automated forecasting platform, by reaching the price target forecast with a 9.69% profit margin....

TMOMay 21, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with 11.36% Profit  ~1 min.

On April 14, 2025, QuantWave's forecasting system signaled a short direction for Thermo Fisher Scientific Inc. with the stock trading at $448.86. Fast forward to May 21, 2025, the target price of $397....

TMOMay 21, 2025Thermo Fisher Scientific Inc. Price Target Forecast Achieved with 9.1% Profit: QuantWave Analysis  ~1 min.

Thermo Fisher Scientific Inc. has successfully reached the price target as forecasted by QuantWave, resulting in a 9.1% profit for investors....

TMOApril 4, 2025Thermo Fisher Scientific Inc. Stock Hits Target Forecast with 14.76% Profit Gain  ~2 min.

In an impressive display of accuracy and insight, QuantWave's forecast for Thermo Fisher Scientific Inc. stock has successfully hit its target, resulting in a profit gain of 14.76%....



Related news

IBMFebruary 2, 2025IBM announces groundbreaking partnership with leading tech company  ~2 min.

International Business Machines Corporation (IBM), a global technology company, has recently announced a groundbreaking partnership with a leading tech company....

TFebruary 20, 2025AT&T Inc.: Shaping the Future of Telecommunications  ~2 min.

AT&T Inc. is a leading telecommunications company, revolutionizing the way we connect and communicate....

PFENovember 21, 2024Pfizer Inc. Introduces Groundbreaking Immunotherapy Treatment, Boosting Confidence in PFE Stock  ~2 min.

Pfizer Inc., a leading pharmaceutical company, has announced the development of a groundbreaking immunotherapy treatment that could revolutionize cancer treatment....

AZNFebruary 7, 2025AstraZeneca Plc Reports Strong Q4 2024 Earnings, Impressive Growth Prospects in the Pipeline  ~2 min.

AstraZeneca Plc, a renowned multinational pharmaceutical company, recently released its impressive Q4 2024 earnings report, showcasing remarkable growth prospects in its pipeline....

SKMFebruary 3, 2025SK Telecom Co. Ltd. Launches Aster the AI Assistant, Elevating Digital Experiences  ~2 min.

SK Telecom Co. Ltd., a leading telecommunications company, has recently unveiled its latest innovation, Aster the AI Assistant, aimed at revolutionizing digital experiences....